logo
Experts warn that weight-loss jabs may need to be taken for life

Experts warn that weight-loss jabs may need to be taken for life

Independent08-06-2025
Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.
These drugs, marketed under names such as Mounjaro and Wegovy, function by curbing food cravings. Currently, obese patients can access these injections through NHS prescriptions, following referrals to specialist weight loss clinics typically based in hospitals. Additionally, hundreds of thousands of individuals are obtaining the medication privately through pharmacies.
There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support.
Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise.
Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about.
'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies.
'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS.
'There's no point in most people taking it for a couple of years and then have the weight bouncing back.
'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense.
'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected.
'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further.
'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.'
Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year.
'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said.
'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs.
'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs.
'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was.
'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.'
Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone.
Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle.
'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said.
'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that.
'But we should absolutely all be looking at our diet and all changing our diet, and doing something.'
Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions.
'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said.
'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out.
'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work.
'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer 's disease.
'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.'
Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them.
'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said.
'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified.
'If you do find those side-effects, you can stop taking the drug.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Two killed including school cook, 62, after eating poisonous guacamole as 2 children recover in hospital
Two killed including school cook, 62, after eating poisonous guacamole as 2 children recover in hospital

The Sun

time16 minutes ago

  • The Sun

Two killed including school cook, 62, after eating poisonous guacamole as 2 children recover in hospital

TWO people have died and two children are recovering in hospital after several people were poisoned by a toxic batch of guacamole. The fatally contaminated avocado dip was served up to unsuspecting customers at a food festival before they showed signs of botulism. 4 4 4 School cook Valeria Sollai, 62, is said to have eaten the guacamole and then was rushed to hospital. But she died on Monday after spending weeks on life support. Roberta Pitzalis, 38, also ate the same batch of guacamole at the festival in Sardinia - before dying on August 8. An autopsy confirmed Roberta died from a combination of botulism poisoning and pneumonia. Several others required hospital treatment following the horrifying ordeal at the Fiesta Latina festival. The food event took place in Monserrato, in Cagliari, between July 22-24. One boy and one girl, aged 11 and 14 respectively, remain in hospital and are reported to have eaten from the same batch of guacamole. A post-mortem for Valeria is set to take place. She showed signs of recovery before suffering a relapse and tragically dying. Her cousin Gianni Milia said: "It's absurd that someone goes out for a relaxing evening, goes to a party, eats a sandwich and ends up in the hospital. Woman, 45, becomes second person to die after eating 'toxic broccoli' as 17 others poisoned as veg recalled across Italy "She was with her sisters, they all ate the same sandwich, but only she fell ill." She added: "They were celebrating their older sister's discharge from the hospital. A party turned into a tragedy." Describing Valeria, Monserrato mayor Tomaso Locci said: 'She gave so much for our children. "The news saddens us deeply. We will be present at the funeral as a community, as we were for Roberta Pitzalis, the other victim. "This is a loss that affects us all.' Valeria is survived by her husband, Angelo Aru, and her son Alessandro, a police officer in Campania. In a Facebook post last month, Alessandro spoke about an unnamed patient with 'worsening neurological conditions'. He also made a heartbreaking appeal for people to be more careful with street food. He said: "I strongly advise against eating any food sold at street stalls over the next few weeks." The poisoned 14-year-old girl is being treated at Monserrato Policlinico hospital. Meanwhile, the 11-year-old has been flown to Rome's Gemelli Policlinico and is said to be in a serious condition. What Is It? Botulism is a rare but serious illness caused by a toxin produced by the bacterium Clostridium botulinum. It affects the nervous system, leading to muscle paralysis and breathing difficulties. How is it contracted? The illness usually comes from eating food contaminated with the toxin. This often happens due to improper food processing, such as inadequate canning. Symptoms to watch for: Muscle weakness Difficulty breathing Double vision Difficulty swallowing How serious is it? Botulism can be life-threatening. In severe cases, it can cause death, with around 10 per cent of cases being fatal if not treated promptly. Treatment: If you think you are suffering from botulism poisoning, medical attention is crucial. Treatment typically involves antitoxins and supportive care, including breathing assistance if necessary. Prevention: Ensure proper food processing and handling. Avoid consuming home-canned foods if you're unsure about their safety. It comes amid mounting concern over food safety in Italy following similar events across the country. Another deadly botulism outbreak was reported in the southern region of Calabria earlier this month. It also comes after two people in Italy died after eating a toxic veggie and sausage sandwich in Italy. More than a dozen people were hospitalised after eating the poisoned sandwiches from a food truck near the town of Diamante in Calabria. Tamara D'Acunto, 45, died shortly after eating the panini made with turnip greens - a vegetable similar to broccoli - last week. Luigi Di Sarno, 52, also died after taking a fatal bite from a sandwich bought from the same vendor. In total, 17 other people have so far been hospitalised with food poisoning within 24 to 48 hours of eating the sandwiches. They all showed signs of botulism - which is caused by a toxin that attacks the body's nerves. The illness can lead to muscle paralysis, breathing difficulties and death. It is typically caused by canned, preserved and fermented foods.

Expert reveals common kitchen spices that can kill most viruses and cure colds
Expert reveals common kitchen spices that can kill most viruses and cure colds

Daily Mail​

time16 minutes ago

  • Daily Mail​

Expert reveals common kitchen spices that can kill most viruses and cure colds

An herbal practitioner has shared the plants that he claims are more effective than prescribed medicines. Herbalist Simon Mills appeared on The Diary of a CEO with host Steven Bartlett recently, where he listed his go-to herbal medicines. The author insisted that there are a few common kitchen spices that can combat everything from a common cold to cardiovascular problems. He credited ginger, chili, turmeric, cinnamon and garlic as the household ingredients that can kill most viruses. He also detailed the natural remedy that he claims can cure a cold, involving only ginger and cinnamon. Ginger root is said to contain several healing properties, including antioxidant, anti-inflammatory, anti-nausea, raising body temperature. To effectively use it to combat a cold, Mills said to grate about a 'thumb's size' of the plant into a mug. He then combines it with a stick of cinnamon, which contains healing properties such as digestive support, respiratory relief, menstrual symptoms in women, as well as helping to ease other pain. 'You either grate that if you have a spice mill or you take a teaspoon of already dried spice,' he explained. From there, Mills said he adds hot water, letting it sit for a few minutes before straining it into a separate mug. 'You can feel it warning straight away,' he said. He explained that when you ingest ginger or other similar 'hot plants,' it can help clear out sinuses since ginger contributes to hyperemia - a reflex response to open the blood vessels. Mills said this in turn causes the cells producing mucus to loosen up and can even bring up phlegm from the lungs. 'There's a natural escalator that the body uses to get stuff out of the lungs that [get]s stimulated,' he shared. Mills also said he uses spices like ginger, cinnamon, and turmeric as his 'main go-to' to help fend off cardiovascular problem. In addition, he explained that if you cut turmeric in half, you get curcumin - which acts as an anti-inflammatory. The herb enthusiast also spoke of the benefits of garlic, explaining that when eating raw, the vegetable is a 'very powerful prebiotic' and can help the gut flora. '[I] encourage people not to ask the doc for an antibiotic and use some of these at-home, easy, and free treatments instead,' he said. Although much of the research into herbs and spices as medicine is still in an early stage – and often uses concentrated extracts or large doses you wouldn't get from a normal meal – there are signs that everyday amounts could give your long-term health a boost. The FDA considers herbal supplements as foods, not medicines, so they are not subject to the same testing, manufacturing, and labeling standards and regulations as medicines. According to John Hopkins Medicine, herbal supplements can interact with conventional medicines and may have strong effects. Doctors advise people not to self-diagnose or self-prescribe, and to talk with your healthcare provider before taking herbal supplements.

Viking shares shed 40% of value after weight-loss pill setback
Viking shares shed 40% of value after weight-loss pill setback

Times

timean hour ago

  • Times

Viking shares shed 40% of value after weight-loss pill setback

A biopharma company suffered a near 40 per cent slump in its share price after the results of its experimental weight-loss pill disappointed investors. Data from Viking Therapeutics, which is in a race with multinational pharma companies including Eli Lilly and Novo Nordisk to develop a next-generation oral treatment, showed its drug helped people with obesity lose up to 12.2 per cent of their body weight over 13 weeks, on the highest dose of the medication. Before the keenly awaited results, analysts expected Viking's drug, known as VK2735, to demonstrate weight loss of between 10 per cent and 15 per cent on average. However, shares in the San Diego-based company slumped by more than a third in New York after the data also showed that more patients stopped taking the treatment compared with those who received a placebo in the mid-stage study. Approximately 38 per cent of those taking the highest dose discontinued the medication early. Gastrointestinal side effects were the most common reasons. Novo Nordisk, the Danish company, and Eli Lilly, one of the world's biggest drugs companies, have dominated the initial weight-loss market through their breakthrough injectable treatments, Wegovy and Zepbound, respectively. They are among a pack of companies competing to develop oral therapies, which are deemed more appealing because of their easier dosing regimens. • Ozempic sales 'rise by 500%' after Mounjaro price hike announcement Analysts have estimated the weight-loss market could be worth up to $150 billion by the end of the decade, although shares in Eli Lilly and Novo have dropped in recent months, weighed down by Donald Trump's pharma industry tariff and price-cut threats, competition from copycat US drugs and mixed trial results for next-generation medicines. This month's data from Eli Lilly's experimental pill also disappointed investors, with patients losing an average of 12.4 per cent of their body weight, which was at the lower end of the market's expectations. Analysts also noted that the trial showed worse-than-expected side effects. Novo Nordisk has previously shown its oral weight-loss drug helped trial participants to lose about 15 per cent of their body weight and has been submitted for approval in the US, the world's most lucrative drugs market. Brian Lian, Viking's chief executive, said 'As in prior studies we observed a clear dose response and impressive weight loss across the 13-week treatment period. The progressive nature of the weight-loss curves suggests the potential for further improvement with longer dosing periods.' Viking shares were $17.66, or 42 per cent, lower at $24.43 by lunchtime in New York, valuing the company at $2.8 billion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store